NASDAQ:MASI Masimo - MASI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Masimo Co. Please log in to your account or sign up in order to add this asset to your watchlist. $172.88 -1.54 (-0.88%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$172.34▼$174.1550-Day Range$156.75▼$182.4352-Week Range$108.89▼$184.96Volume150,703 shsAverage Volume362,754 shsMarket Capitalization$9.09 billionP/E Ratio66.49Dividend YieldN/APrice Target$182.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Masimo MarketRank™ ForecastAnalyst RatingModerate Buy2.88 Rating ScoreUpside/Downside5.3% Upside$182.00 Price TargetShort InterestHealthy1.84% of Float Sold ShortDividend StrengthN/ASustainability-0.86Upright™ Environmental ScoreNews Sentiment0.54Based on 14 Articles This WeekInsider TradingN/AProj. Earnings Growth10.95%From $4.75 to $5.27 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.27 out of 5 starsMedical Sector321st out of 1,005 stocksElectromedical Equipment Industry4th out of 24 stocks 1.4 Analyst's Opinion Consensus RatingMasimo has received a consensus rating of Buy. The company's average rating score is 2.88, and is based on 7 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $182.00, Masimo has a forecasted upside of 5.3% from its current price of $172.88.Amount of Analyst CoverageMasimo has only been the subject of 4 research reports in the past 90 days. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.84% of the float of Masimo has been sold short.Short Interest Ratio / Days to CoverMasimo has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Masimo has recently decreased by 6.63%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldMasimo does not currently pay a dividend.Dividend GrowthMasimo does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreMasimo has received a 61.97% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "ECG monitors" product. See details.Environmental SustainabilityThe Environmental Impact score for Masimo is -0.86. Previous Next 2.5 News and Social Media Coverage News SentimentMasimo has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Masimo this week, compared to 5 articles on an average week.Search Interest18 people have searched for MASI on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Masimo to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Masimo insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 9.70% of the stock of Masimo is held by insiders.Percentage Held by Institutions87.67% of the stock of Masimo is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Masimo are expected to grow by 10.95% in the coming year, from $4.75 to $5.27 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Masimo is 66.49, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 123.26.Price to Earnings Ratio vs. SectorThe P/E ratio of Masimo is 66.49, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 123.61.Price to Book Value per Share RatioMasimo has a P/B Ratio of 6.79. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Masimo (NASDAQ:MASI) StockMasimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. Its products include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet, Masimo Patient SafetyNet Surveillance, Masimo SafetyNet, Masimo SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridge. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.Read More Receive MASI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter. Email Address MASI Stock News HeadlinesMarch 24, 2023 | americanbankingnews.comZacks Research Analysts Boost Earnings Estimates for Masimo Co. (NASDAQ:MASI)March 23, 2023 | finance.yahoo.comMasimo Announces Changes to Governance Structure and PracticesMarch 26, 2023 | Weiss Ratings (Ad)Banking NightmareDuring and after the Great Financial Crisis of 2008, 485 U.S. banks went under. Here at Weiss Ratings, we warned about 484 — an accuracy rate of 99.8%. Now, we have a new warning. But this time, it's not just about a few hundred banks … it's about nearly every single bank in America …March 23, 2023 | finance.yahoo.comUPDATE 2-Masimo CEO waives right to $600 mln payout in fight with activist investorMarch 22, 2023 | finance.yahoo.comThree Reasons to Add Masimo (MASI) Stock to Your PortfolioMarch 20, 2023 | marketwatch.comHandheld Pulse Oximetry Market Statistics [2023-2028]: Emerging Trends and Future Growth ScenarioMarch 20, 2023 | americanbankingnews.comMasimo (NASDAQ:MASI) Now Covered by Analysts at StockNews.comMarch 19, 2023 | americanbankingnews.comBrokers Set Expectations for Masimo Co.'s Q2 2023 Earnings (NASDAQ:MASI)March 26, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. March 17, 2023 | finance.yahoo.comMasimo (MASI) Moves to Strong Buy: Rationale Behind the UpgradeMarch 17, 2023 | americanbankingnews.comMasimo Co. (NASDAQ:MASI) Short Interest UpdateMarch 16, 2023 | finance.yahoo.comMasimo (MASI) PVi Achieves Acceptable Fluid Response in StudyMarch 16, 2023 | americanbankingnews.comQ1 2023 EPS Estimates for Masimo Co. (NASDAQ:MASI) Decreased by Zacks ResearchMarch 15, 2023 | finance.yahoo.comEuropean Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin MonitoringMarch 9, 2023 | businesswire.comNew Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing NeurosurgeryMarch 6, 2023 | businesswire.comNew Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical PatientsMarch 3, 2023 | benzinga.com$300B California Teachers Pension Fund Joins Politan Capital In Legal Action Against Masimo CEO's Employment AgreementMarch 2, 2023 | finance.yahoo.comMasimo to Present in 44th Annual Raymond James Institutional Investors ConferenceMarch 1, 2023 | finance.yahoo.comMasimo (NASDAQ:MASI) investors are up 5.1% in the past week, but earnings have declined over the last five yearsMarch 1, 2023 | finance.yahoo.comMasimo Reports Fourth Quarter and Full-Year 2022 Financial ResultsMarch 1, 2023 | finance.yahoo.comMasimo (MASI) Q4 Earnings and Revenues Beat EstimatesMarch 1, 2023 | finance.yahoo.comMasimo (MASI) Q4 Earnings Surpass Estimates, Margins DownMarch 1, 2023 | finance.yahoo.comQ4 2022 Masimo Corp Earnings CallFebruary 23, 2023 | msn.comExpert Ratings for MasimoFebruary 22, 2023 | finance.yahoo.comAnalyst Says This MedTech Giant Stock Offers 'Too Much Optionality,' Upgrades RatingFebruary 15, 2023 | finance.yahoo.comMasimo Centroid® Receives Innovative Technology Designation from VizientFebruary 14, 2023 | finance.yahoo.comAnalysts Estimate Masimo (MASI) to Report a Decline in Earnings: What to Look Out forSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MASI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Masimo and its competitors with MarketBeat's FREE daily newsletter. Email Address MASI Company Calendar Last Earnings2/28/2023Today3/25/2023Next Earnings (Estimated)5/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:MASI CUSIP57479510 CIK937556 Webwww.masimo.com Phone(949) 297-7000Fax949-297-7001Employees6,000Year Founded1989Price Target and Rating Average Stock Price Forecast$182.00 High Stock Price Forecast$206.00 Low Stock Price Forecast$150.00 Forecasted Upside/Downside+5.3%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)$2.60 Trailing P/E Ratio66.49 Forward P/E Ratio36.40 P/E GrowthN/ANet Income$143.50 million Net Margins7.06% Pretax Margin9.50% Return on Equity18.84% Return on Assets9.09% Debt Debt-to-Equity Ratio0.70 Current Ratio2.08 Quick Ratio1.28 Sales & Book Value Annual Sales$2.04 billion Price / Sales4.47 Cash Flow$7.38 per share Price / Cash Flow23.44 Book Value$25.45 per share Price / Book6.79Miscellaneous Outstanding Shares52,600,000Free Float47,500,000Market Cap$9.09 billion OptionableOptionable Beta0.86 Social Links Key ExecutivesJoe E. KianiChairman & Chief Executive OfficerBilal MuhsinChief Operating OfficerMicah YoungChief Financial Officer & Executive Vice PresidentYongsam LeeChief Information Officer & Executive VPAnand SampathExecutive VP-Operations & Clinical ResearchKey CompetitorsIntegerNYSE:ITGRCONMEDNYSE:CNMDInModeNASDAQ:INMDTransMedics GroupNASDAQ:TMDXLivaNovaNASDAQ:LIVNView All CompetitorsInsiders & InstitutionsRockefeller Capital Management L.P.Sold 126,326 shares on 3/6/2023Ownership: 0.023%North Star Asset Management Inc.Sold 2,022 shares on 3/6/2023Ownership: 0.011%Voya Investment Management LLCSold 75 shares on 2/28/2023Ownership: 0.037%Macquarie Group Ltd.Sold 426 shares on 2/21/2023Ownership: 0.008%Northwestern Mutual Wealth Management Co.Sold 421 shares on 2/21/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions MASI Stock - Frequently Asked Questions Should I buy or sell Masimo stock right now? 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Masimo in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MASI shares. View MASI analyst ratings or view top-rated stocks. What is Masimo's stock price forecast for 2023? 8 brokerages have issued 12-month price targets for Masimo's stock. Their MASI share price forecasts range from $150.00 to $206.00. On average, they predict the company's stock price to reach $182.00 in the next twelve months. This suggests a possible upside of 5.3% from the stock's current price. View analysts price targets for MASI or view top-rated stocks among Wall Street analysts. How have MASI shares performed in 2023? Masimo's stock was trading at $147.95 at the beginning of 2023. Since then, MASI stock has increased by 16.9% and is now trading at $172.88. View the best growth stocks for 2023 here. When is Masimo's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023. View our MASI earnings forecast. How were Masimo's earnings last quarter? Masimo Co. (NASDAQ:MASI) posted its quarterly earnings results on Tuesday, February, 28th. The medical equipment provider reported $1.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.15. The medical equipment provider had revenue of $617 million for the quarter, compared to analyst estimates of $602.49 million. Masimo had a trailing twelve-month return on equity of 18.84% and a net margin of 7.06%. Masimo's revenue was up 88.4% on a year-over-year basis. During the same period in the prior year, the firm posted $1.21 earnings per share. What ETFs hold Masimo's stock? ETFs with the largest weight of Masimo (NASDAQ:MASI) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), First Trust Indxx Medical Devices ETF (MDEV), Global X Founder-Run Companies ETF (BOSS), BlackRock Future Health ETF (BMED), Neuberger Berman Disrupters ETF (NBDS), SPDR S&P Health Care Equipment ETF (XHE) and ROBO Global Healthcare Technology and Innovation ETF (HTEC). What guidance has Masimo issued on next quarter's earnings? Masimo updated its first quarter 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share (EPS) guidance of $0.81-$0.86 for the period, compared to the consensus earnings per share estimate of $0.93. The company issued revenue guidance of $550.00 million-$565.00 million, compared to the consensus revenue estimate of $553.42 million. What is Joe E. Kiani's approval rating as Masimo's CEO? 136 employees have rated Masimo Chief Executive Officer Joe E. Kiani on Glassdoor.com. Joe E. Kiani has an approval rating of 90% among the company's employees. What other stocks do shareholders of Masimo own? Based on aggregate information from My MarketBeat watchlists, some companies that other Masimo investors own include NVIDIA (NVDA), Netflix (NFLX), Shopify (SHOP), Okta (OKTA), PayPal (PYPL), Alibaba Group (BABA), Mastercard (MA), Trade Desk (TTD), Walt Disney (DIS) and Twilio (TWLO). What is Masimo's stock symbol? Masimo trades on the NASDAQ under the ticker symbol "MASI." Who are Masimo's major shareholders? Masimo's stock is owned by many different institutional and retail investors. Top institutional investors include Liontrust Investment Partners LLP (1.81%), Fundsmith LLP (1.45%), Geode Capital Management LLC (1.34%), Schroder Investment Management Group (1.10%), Martin Currie Ltd. (1.04%) and T. Rowe Price Investment Management Inc. (1.03%). Insiders that own company stock include Adam Mikkelson, Anand Sampath, Bilal Muhsin, Craig B Reynolds, H Michael Cohen, Joe E Kiani, Jon Coleman, Micah W Young, Ramshorst David J Van, Tao Levy, Thomas Samuel Mcclenahan and Yongsam Lee. View institutional ownership trends. How do I buy shares of Masimo? Shares of MASI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Masimo's stock price today? One share of MASI stock can currently be purchased for approximately $172.88. How much money does Masimo make? Masimo (NASDAQ:MASI) has a market capitalization of $9.09 billion and generates $2.04 billion in revenue each year. The medical equipment provider earns $143.50 million in net income (profit) each year or $2.60 on an earnings per share basis. How many employees does Masimo have? The company employs 6,000 workers across the globe. How can I contact Masimo? Masimo's mailing address is 52 DISCOVERY, IRVINE CA, 92618. The official website for the company is www.masimo.com. The medical equipment provider can be reached via phone at (949) 297-7000, via email at ekammerman@masimo.com, or via fax at 949-297-7001. This page (NASDAQ:MASI) was last updated on 3/26/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.